Private Advisor Group, LLC Palisade Bio, Inc. Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
BUY
$0.41 - $1.04 $2,050 - $5,200
5,000 Added 17.54%
33,500 $14,000
Q4 2021

Feb 10, 2022
BUY
$1.3 - $2.96 $6,433 - $14,649
4,949 Added 21.01%
28,500 $37,000
Q3 2021

Oct 14, 2021
BUY
$2.35 - $3.93 $5,875 - $9,825
2,500 Added 11.88%
23,551 $62,000
Q2 2021

Aug 12, 2021
BUY
$3.49 - $11.34 $73,467 - $238,718
21,051 New
21,051 $86,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email